Ina Yasuhiro, Sakai Kazuo
Low Dose Radiation Research Center, Central Research Institute of Electric Power Industry, 2-11-1 Iwado-kita, Komae, Tokyo, 201-8511, Japan.
Radiat Res. 2005 Apr;163(4):418-23. doi: 10.1667/rr3316.
MRL-lpr/lpr mice carry a deletion in the apoptosis-regulating Fas gene that markedly shortens life due to multiple severe diseases. In our previous study (Radiat. Res. 161, 168- 173, 2004), chronic low-dose-rate gamma irradiation of mice at 0.35 or 1.2 mGy/h for 5 weeks markedly prolonged the life span, accompanied by immunological activation. This report shows that extension of the irradiation period to the entire life of the mice at the same dose rates improved survival further. The 50% survival time for untreated mice, 134 days, was prolonged to 502 days by 1.2 mGy/h life-long irradiation. Also obtained were a time course and a radiation dose-rate response for the activation of the immune system as indicated by a significant increase in CD4+ CD8+ T cells in the thymus and CD8+ T cells in the spleen and also by a significant decrease in CD3+ CD45R/B220+ cells and CD45R/B220+ CD40+ cells in the spleen. Drastic ameliorations of multiple severe diseases, i.e. total-body lymphadenopathy, splenomegaly and serious autoimmune diseases including proteinuria, and kidney and brain-central nervous system syndromes, were found in parallel with these immunological activations, with lifelong low-dose-rate irradiation being more effective than 5-week irradiation at low dose rates.
MRL-lpr/lpr小鼠的凋亡调节基因Fas存在缺失,这会因多种严重疾病显著缩短寿命。在我们之前的研究(《辐射研究》第161卷,第168 - 173页,2004年)中,以0.35或1.2 mGy/h的剂量率对小鼠进行5周的慢性低剂量率γ射线照射,显著延长了其寿命,并伴有免疫激活。本报告表明,在相同剂量率下将照射期延长至小鼠的整个生命期可进一步提高生存率。未经处理的小鼠的50%存活时间为134天,通过1.2 mGy/h的终身照射延长至502天。还获得了免疫系统激活的时间进程和辐射剂量率响应,表现为胸腺中CD4 + CD8 + T细胞以及脾脏中CD8 + T细胞显著增加,同时脾脏中CD3 + CD45R/B220 + 细胞和CD45R/B220 + CD40 + 细胞显著减少。与这些免疫激活同时发现,多种严重疾病,即全身淋巴结病、脾肿大以及包括蛋白尿、肾脏和脑 - 中枢神经系统综合征在内的严重自身免疫性疾病得到了显著改善,终身低剂量率照射比低剂量率的5周照射更有效。